Skin-derived ABCB5-positive Mesenchymal Stem cells

DB17862InvestigationalCell transplant therapies

Skin-derived ABCB5-positive Mesenchymal Stem cells are under investigation in clinical trial NCT04971161 (Allogeneic Abcb5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase Iib)).

Also known as: ABCB5+ MSCs · allo-APZ2-ACLF · allo-APZ2-CVU · allo-APZ2-DFU · allo-APZ2-EB

Resolves to

Targets

Q2M3G0ABCB5

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Skin-derived ABCB5-positive Mesenchymal Stem cells, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account